Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA
- PMID: 3285295
Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA
Abstract
Amplification of the neu (or c-erbB-2 or HER) oncogene is relatively frequent in human breast carcinomas. We have raised a polyclonal rabbit serum in order to detect the neu protein product in tissue sections of tumors. This serum specifically reacted with a 185 kilodaltons neu protein in SKBR-3 cells, a mammary carcinoma cell line with amplified neu. Immunohistochemistry on paraffin-embedded sections of tumors in which the neu gene was amplified showed distinct membrane staining of groups of tumor cells. Sections of tumors with normal copy numbers of neu were negative. Lymph node metastases from tumors positive for neu overexpression also showed the membrane staining pattern, whereas lymph node metastases from tumors negative for neu staining never did. Neu amplification is thus associated with neu protein overproduction in tumors and lymph node metastases, and a routine antibody staining technique can discriminate a high level of neu protein expression from levels commonly present in tumors with normal neu copy numbers.
Similar articles
-
Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.Cancer Res. 1993 Oct 15;53(20):4960-70. Cancer Res. 1993. PMID: 8104689
-
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.N Engl J Med. 1988 Nov 10;319(19):1239-45. doi: 10.1056/NEJM198811103191902. N Engl J Med. 1988. PMID: 2903446
-
HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.Anticancer Res. 1992 Mar-Apr;12(2):419-25. Anticancer Res. 1992. PMID: 1349794
-
Neu (C-erbB-2) oncogene in breast cancer and its possible association with the risk of distant metastases. A retrospective study and review of literature.Acta Oncol. 1990;29(7):931-4. doi: 10.3109/02841869009096392. Acta Oncol. 1990. PMID: 1979748 Review.
-
The neu (c-erbB-2) oncogene.Semin Oncol. 1989 Apr;16(2):148-55. Semin Oncol. 1989. PMID: 2565604 Review.
Cited by
-
Role of HER2-neu as a prognostic factor for survival and relapse in pT1a-bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis.Med Oncol. 2012 Dec;29(4):2586-93. doi: 10.1007/s12032-012-0201-4. Epub 2012 Mar 14. Med Oncol. 2012. PMID: 22415399
-
Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients.J Cancer Res Clin Oncol. 1993;119(5):249-52. doi: 10.1007/BF01212719. J Cancer Res Clin Oncol. 1993. PMID: 8095050 Free PMC article.
-
An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.Br J Cancer. 1989 Sep;60(3):426-9. doi: 10.1038/bjc.1989.299. Br J Cancer. 1989. PMID: 2571356 Free PMC article.
-
Negative autoregulation of the neu gene is mediated by a novel enhancer.Mol Cell Biol. 1992 Jun;12(6):2739-48. doi: 10.1128/mcb.12.6.2739-2748.1992. Mol Cell Biol. 1992. PMID: 1350324 Free PMC article.
-
c-erbB2 expression in correlation to other biological parameters of breast cancer.J Cancer Res Clin Oncol. 1990;116(1):15-20. doi: 10.1007/BF01612634. J Cancer Res Clin Oncol. 1990. PMID: 1968902 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous